Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved bioavailability of para-boronophenylalanine by cyclodextrin complexation

H Hatanaka1, F Komada, Y Mishima

  • 1Hyogo Prefectural Institute of Public Health, Kobe, Japan.

Journal of Pharmaceutical Sciences
|October 1, 1993
PubMed
Summary

Developing oral para-boronophenylalanine (BPA) with cyclodextrin (CD) enhances its bioavailability. Specific BPA-CD complexes improved drug solubility and release, crucial for effective thermal neutron capture therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inspection of thick welded joints using laser-ultrasonic SAFT.

Ultrasonics·2016
Same author

Reviewing Leung's technique of using trephines for scaphoid nonunion.

The Journal of hand surgery, European volume·2013
Same author

Intraluminal injection of indigo carmine facilitates identification of the afferent limb during double-balloon ERCP.

Endoscopy·2012
Same author

Localization of angiotensin-converting enzyme, prolyl endopeptidase and other peptidases in cultured neuronal or glial cells.

Neurochemistry international·2010
Same author

High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays.

Leukemia·2008
Same author

MicroRNA expression profiles of human leukemias.

Leukemia·2007

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science

Background:

  • Malignant melanoma treatment often requires targeted therapies.
  • Para-boronophenylalanine (BPA) is used in thermal neutron capture therapy (BNCT).
  • Developing oral dosage forms for BNCT agents like BPA is challenging due to bioavailability issues.

Purpose of the Study:

  • To develop an oral dosage form of para-boronophenylalanine (BPA) complexed with cyclodextrins (CDs).
  • To evaluate the impact of different cyclodextrins on BPA solubility, release rate, and oral bioavailability.
  • To assess the potential of these complexes for improved thermal neutron capture therapy.

Main Methods:

  • Complexation of BPA with various cyclodextrins (alpha-CD, G1-alpha-CD, G2-alpha-CD, G2G2, G2-beta-CD) at a 1:2 molar ratio.
  • Characterization of BPA-CD complexes using X-ray diffraction to determine solid-state properties.

Related Experiment Videos

  • Assessment of BPA solubility and release rates from different complexes.
  • Evaluation of oral bioavailability of BPA in rat models following administration of BPA-CD complexes.

    • Main Results:

    • Amorphous BPA-CD complexes were formed, confirmed by X-ray diffraction.
    • Glucosyl (G1)- and maltosyl (G2)-alpha-CD significantly enhanced BPA solubility compared to other CDs.
    • Oral administration of BPA-alpha-CD, G1-alpha-CD, and G2-alpha-CD complexes improved BPA bioavailability in rats.
    • Complexes with low release rates and solubility (BPA-G2G2, BPA-G2-beta-CD) did not enhance bioavailability.

    Conclusions:

    • The solubility and release rate of BPA from cyclodextrin complexes are critical factors for oral bioavailability.
    • Optimized BPA-CD formulations, particularly with G1-alpha-CD and G2-alpha-CD, show promise for oral administration in BNCT.
    • Further development of these oral dosage forms could improve patient compliance and therapeutic outcomes for malignant melanoma.